Coordinatore | LIVERPOOL SCHOOL OF TROPICAL MEDICINE
Organization address
address: Pembroke Place contact info |
Nazionalità Coordinatore | United Kingdom [UK] |
Totale costo | 560˙747 € |
EC contributo | 500˙000 € |
Programma | FP7-HEALTH
Specific Programme "Cooperation": Health |
Code Call | FP7-HEALTH-2007-B |
Funding Scheme | CSA-CA |
Anno di inizio | 2009 |
Periodo (anno-mese-giorno) | 2009-02-01 - 2011-06-30 |
# | ||||
---|---|---|---|---|
1 |
LIVERPOOL SCHOOL OF TROPICAL MEDICINE
Organization address
address: Pembroke Place contact info |
UK (LIVERPOOL) | coordinator | 292˙100.00 |
2 |
Medicines for Malaria Venture
Organization address
address: ROUTE DE PRE BOIS 20 contact info |
CH (GENEVE) | participant | 58˙650.00 |
3 |
WORLD HEALTH ORGANIZATION.
Organization address
address: Avenue Appia 20 contact info |
CH (GENEVE) | participant | 58˙650.00 |
4 |
UNIVERSITY OF CAPE TOWN
Organization address
address: PRIVATE BAG X3 contact info |
ZA (RONDEBOSCH) | participant | 30˙000.00 |
5 |
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE
Organization address
address: Rue Michel -Ange 3 contact info |
FR (PARIS) | participant | 12˙650.00 |
6 |
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM)
Organization address
address: 101 Rue de Tolbiac contact info |
FR (PARIS) | participant | 12˙650.00 |
7 |
UNIVERSITA DEGLI STUDI DI MILANO
Organization address
address: Via Festa Del Perdono 7 contact info |
IT (MILANO) | participant | 12˙650.00 |
8 |
UNIVERSITAETSKLINIKUM HEIDELBERG
Organization address
address: IM NEUENHEIMER FELD 672 contact info |
DE (HEIDELBERG) | participant | 12˙650.00 |
9 |
UNIVERSITY OF BUEA
Organization address
address: PO BOX 63 contact info |
CM (BUEA SOUTHWEST REGION) | participant | 10˙000.00 |
Esplora la "nuvola delle parole (Word Cloud) per avere un'idea di massima del progetto.
'Antimalarial drug discovery and development initiatives globally are fragmented and uncoordinated. We have brought together key organisations including MMV, WHO and AntiMal, an EU-funded FP6 Integrated Project represented by its coordinating institution and a number of academic malaria researchers, to resolve this problem through a logical series of meetings, conferences, workshops and dissemination strategies. The Gates Foundation will be involved as an invited participant. The action will co-ordinate leading European malaria research initiatives in antimalarial drug discovery and development, co-ordinate the European effort with international initiatives, engage industry and provide guidance on standardisation of core requirements of regulatory drug development. This will contribute towards generating global priorities and prepare the European antimalarial research agenda for the next decade.'